Mesa Laboratories (MLAB)
(Delayed Data from NSDQ)
$129.98 USD
+3.83 (3.04%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $130.49 +0.51 (0.39%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth F Momentum B VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
MLAB 129.98 +3.83(3.04%)
Will MLAB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MLAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLAB
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
Surging Earnings Estimates Signal Upside for Mesa Labs (MLAB) Stock
MLAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Mesa Labs (MLAB) Moves to Strong Buy: Rationale Behind the Upgrade
New Strong Buy Stocks for August 26th
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
Other News for MLAB
Mesa Laboratories Inc (MLAB) Shares Up 4.12% on Sep 17
Foot Locker trips after earnings, Kohl's posts Q2 beat: Morning Buzz
Ex-Dividend Reminder: Mesa Laboratories, Perrigo and McKesson
Illumina upgraded, Fiserv initiated: Wall Street's top analyst calls
Conestoga Capital Advisors Q2 2024 Commentary